Jeffrey William Henderson - Sep 1, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Michael Hom, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Sep 1, 2023
Transactions value $
-$2,060
Form type
4
Date filed
9/6/2023, 08:54 PM
Previous filing
Aug 8, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$2.06K -2K -6.48% $1.03 28.9K Sep 1, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.
F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.970 to $1.075. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.